13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q4 2016. See the latest, Q2 2026 →
Reported value
$398.65B
−0.1% on the quarter before
Positions
2,172
224 new · 226 sold out
Top 10
15.4%
of the value
Est. gain
+$9.00B
on stocks held all quarter
Est. return
+2.5%
on those stocks since Q3 2016
Positions as of Dec 31, 2016, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 29% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2016. Striped tiles are options.
Largest buys
Since Q3 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Transcanada Corp~$981.0MNew · 0.0% → 0.2%+21,730,412 shares
- Eli Lilly~$857.7MAdded · 0.9% → 1.0%+11,661,776 shares
- Bank Amer Corp~$730.1MAdded · 0.7% → 1.1%+33,037,351 shares
- Bristol Myers Squibb Co~$690.7MAdded · 1.8% → 2.2%+11,818,681 shares
- Qualcomm~$671.1MAdded · 0.2% → 0.3%+10,292,872 shares
- Baker Hughes Inc~$666.1MAdded · 0.1% → 0.3%+10,252,177 shares
- Hilton Worldwide Hldgs Inc~$621.0MAdded · 0.2% → 0.5%+22,831,599 shares
- American Tower~$606.2MAdded · 0.4% → 0.5%+5,736,298 shares
- Envision Healthcare Corp~$595.2MNew · 0.0% → 0.1%+9,403,901 shares
- Unilever N V~$544.7MAdded · 0.1% → 0.2%+13,265,368 shares
Largest sells
Since Q3 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Unitedhealth Group Inc~$1.81BCut · 1.8% → 1.6%−11,331,071 shares
- Merck & Co Inc~$1.57BCut · 2.4% → 1.8%−26,628,351 shares
- Select Sector SPDR TrPUT~$1.02BCut · 0.0% → 0.0%−23,539,413 underlying
- Nxp Semiconductors N V~$986.7MCut · 0.3% → 0.1%−10,066,893 shares
- Incyte Corp~$686.0MCut · 0.6% → 0.5%−6,841,945 shares
- BlackRock~$685.4MCut · 0.8% → 0.7%−1,801,042 shares
- Colgate Palmolive Co~$664.9MCut · 0.6% → 0.4%−10,160,205 shares
- Honeywell Technologies~$615.4MCut · 0.9% → 0.7%−5,311,796 shares
- Anadarko Pete Corp~$601.5MCut · 0.5% → 0.4%−8,626,362 shares
- Amazon~$593.0MCut · 0.7% → 0.5%−790,756 shares
Holdings
As of Dec 31, 2016. Changes are in shares against Sep 30, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb CoCOM · shares +8.7% · price +8.4% | 2.2% | $8.66B | +$616.6M | ||||||||
| MicrosoftCOM · shares −1.0% · price +7.9% | 2.1% | $8.44B | +$616.8M | ||||||||
| Merck & Co IncCOM · shares −18% · price −5.7% | 1.8% | $7.31B | −$439.6M | ||||||||
| Unitedhealth Group IncCOM · shares −22% · price +14.3% | 1.6% | $6.33B | +$792.3M | ||||||||
| Jpmorgan Chase & CoCOM · shares −4.1% · price +29.6% | 1.4% | $5.62B | +$1.28B | ||||||||
| Wells Fargo & Co NewCOM · shares −4.5% · price +24.5% | 1.4% | $5.54B | +$1.09B | ||||||||
| Medtronic PlcSHS · shares +1.6% · price −17.6% | 1.3% | $5.33B | −$1.12B | ||||||||
| Pnc Finl Svcs Group IncCOM · shares −2.7% · price +29.8% | 1.2% | $4.77B | +$1.10B | ||||||||
| Allergan PlcSHS · shares −6.1% · price −8.8% | 1.2% | $4.76B | −$460.5M | ||||||||
| Chevron Corp NewCOM · shares −0.4% · price +14.4% | 1.2% | $4.76B | +$597.6M | ||||||||
| Bank Amer CorpCOM · shares +19% · price +41.2% | 1.1% | $4.52B | +$1.10B | ||||||||
| IntelCOM · shares +1.1% · price −3.9% | 1.1% | $4.46B | −$180.1M | ||||||||
| Exxon Mobil CorpCOM · shares −4.0% · price +3.4% | 1.1% | $4.43B | +$146.2M | ||||||||
| Chubb LimitedCOM · shares −2.5% · price +5.1% | 1.1% | $4.39B | +$215.0M | ||||||||
| Eli LillyCOM · shares +26% · price −8.4% | 1.0% | $4.18B | −$302.9M | ||||||||
| AppleCOM · shares +5.0% · price +2.5% | 1.0% | $4.09B | +$93.2M | ||||||||
| Johnson & JohnsonCOM · shares −9.2% · price −2.5% | 1.0% | $4.01B | −$101.6M | ||||||||
| AlphabetCAP STK CL A · shares −7.8% · price −1.4% | 0.83% | $3.32B | −$48.6M | ||||||||
| United Parcel Service IncCL B · shares −4.3% · price +4.8% | 0.81% | $3.24B | +$149.3M | ||||||||
| Verizon Communications IncCOM · shares −3.4% · price +2.7% | 0.81% | $3.22B | +$84.4M | ||||||||
| Mckesson CorpCOM · shares +1.3% · price −15.8% | 0.79% | $3.17B | −$585.1M | ||||||||
| Comcast Corp NewCL A · shares −11% · price +4.1% | 0.79% | $3.15B | +$123.8M | ||||||||
| CiscoCOM · shares −11% · price −4.7% | 0.77% | $3.07B | −$152.4M | ||||||||
| Marsh & Mclennan Cos IncCOM · shares −11% · price +0.5% | 0.74% | $2.96B | +$14.9M | ||||||||
| Honeywell TechnologiesCOM · shares −17% · price −0.6% | 0.73% | $2.90B | −$18.5M | ||||||||
| Total · 2,172 positions | 100% | $398.65B | +$9.00B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2016 to Q4 2016: 1,852 stocks held throughout, up $9.00B (+2.5%).
- Jpmorgan Chase & Co+$1.28B+30%
- Bank Amer Corp+$1.10B+41%
- Pnc Finl Svcs Group Inc+$1.10B+30%
- Wells Fargo & Co New+$1.09B+24%
- Unitedhealth Group Inc+$792.3M+14%
- Alnylam Pharmaceuticals Inc−$364.0M−45%
- Merck & Co Inc−$439.6M−6%
- Allergan Plc−$460.5M−9%
- Mckesson Corp−$585.1M−16%
- Medtronic Plc−$1.12B−18%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 3 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |